The role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcutaneous Syrian hamster tumors
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcutaneous Syrian hamster tumors
Authors
Keywords
-
Journal
CANCER GENE THERAPY
Volume 20, Issue 9, Pages 521-530
Publisher
Springer Nature
Online
2013-08-09
DOI
10.1038/cgt.2013.49
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus
- (2011) Vincenzo Cerullo et al. MOLECULAR THERAPY
- A fully replication-competent adenovirus vector with enhanced oncolytic properties
- (2010) K Toth et al. CANCER GENE THERAPY
- Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir
- (2010) Iulia Diaconu et al. JOURNAL OF GENE MEDICINE
- Oncolytic Adenoviruses for the Treatment of Human Cancer: Focus on Translational and Clinical Data
- (2010) Sari Pesonen et al. MOLECULAR PHARMACEUTICS
- Increasing the Efficacy of Oncolytic Adenovirus Vectors
- (2010) Karoly Toth et al. Viruses-Basel
- New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster
- (2009) J F Spencer et al. CANCER GENE THERAPY
- INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies
- (2009) B Ying et al. CANCER GENE THERAPY
- An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector
- (2009) D L Lichtenstein et al. CANCER GENE THERAPY
- Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide
- (2009) X. Q. Lun et al. CLINICAL CANCER RESEARCH
- Treatment of Pancreatic Cancer With an Oncolytic Adenovirus Expressing Interleukin-12 in Syrian Hamsters
- (2009) Sergia Bortolanza et al. MOLECULAR THERAPY
- Pre-existing Immunity and Passive Immunity to Adenovirus 5 Prevents Toxicity Caused by an Oncolytic Adenovirus Vector in the Syrian Hamster Model
- (2009) Debanjan Dhar et al. MOLECULAR THERAPY
- Current Issues and Future Directions of Oncolytic Adenoviruses
- (2009) Masato Yamamoto et al. MOLECULAR THERAPY
- Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats
- (2008) A M Sonabend et al. CANCER GENE THERAPY
- Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of Reovirus
- (2008) J. Qiao et al. CLINICAL CANCER RESEARCH
- Effect of Preexisting Immunity on Oncolytic Adenovirus Vector INGN 007 Antitumor Efficacy in Immunocompetent and Immunosuppressed Syrian Hamsters
- (2008) D. Dhar et al. JOURNAL OF VIROLOGY
- Immunosuppression Enhances Oncolytic Adenovirus Replication and Antitumor Efficacy in the Syrian Hamster Model
- (2008) Maria A Thomas et al. MOLECULAR THERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started